Article
Cardiac & Cardiovascular Systems
Fraser J. Graham, Gabriele Masini, Pierpaolo Pellicori, John G. F. Cleland, Nicola Greenlaw, Jocelyn Friday, Syed Kazmi, Andrew L. Clark
Summary: Iron deficiency and anaemia are common in chronic heart failure patients, with high rates of incidence and resolution. Persistent or incident iron deficiency is associated with higher mortality, while resolution of iron deficiency is associated with lower mortality. Anaemia, even if resolved, is still associated with poor outcomes.
EUROPEAN JOURNAL OF HEART FAILURE
(2022)
Article
Hematology
Ronak H. Mistry, Andrew Kohut, Patricia Ford
Summary: Iron deficiency in heart failure patients is associated with increased mortality, but diagnosing it can be challenging. While intravenous iron supplementation has been shown to be superior, diagnosing ID in hospitalized patients remains a challenge. Our study found no significant difference in readmission rates or mortality between HF patients who received IVFe treatment and those who did not.
ANNALS OF HEMATOLOGY
(2021)
Article
Gastroenterology & Hepatology
Jassin Rashidi-Alavijeh, Nargiz Nuruzade, Alexandra Frey, Eva-Maria Huessler, Anne Hoerster, Amos Cornelius Zeller, Andreas Schuette, Hartmut Schmidt, Katharina Willuweit, Christian Markus Lange
Summary: This study aimed to evaluate the role of iron supplementation in improving the prognosis of patients with cirrhosis. The results showed that an increase in hemoglobin levels was associated with improved transplant-free survival in patients with cirrhosis. The combination of iron supplementation and rifaximin had a stronger effect on prognosis.
Article
Medicine, General & Internal
Carles Diez-Lopez, Marta Tajes Orduna, Cristina Enjuanes Grau, Pedro Moliner Borja, Jose Gonzalez-Costello, Elena Garcia-Romero, Josep Francesch Manzano, Sergi Yun Viladomat, Santiago Jimenez-Marrero, Raul Ramos-Polo, Maria del Mar Ras Jimenez, Josep Comin-Colet
Summary: This study investigated the biological mechanisms between heart failure and iron deficiency and identified potential prognostic biomarkers through blood gene expression patterns. Patients with systemic iron deficiency in heart failure showed lower levels of key genes in blood, which correlated with adverse clinical outcomes.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Gabriele Masini, Fraser J. Graham, Pierpaolo Pellicori, John G. F. Cleland, Joseph J. Cuthbert, Syed Kazmi, Riccardo M. Inciardi, Andrew L. Clark
Summary: Different definitions of iron deficiency (ID) lead to inconsistent prevalence and prognosis. Definitions lacking specificity may attenuate the benefits of intravenous iron therapy, while definitions lacking sensitivity may exclude patients who should receive intravenous iron therapy.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2022)
Article
Engineering, Biomedical
Selim Bozkurt
Summary: This study evaluates the effects of anaemia on cardiac function and cerebral blood flow in heart failure patients supported with CF-LVAD using computational simulations. The results show that reduced haemoglobin levels increase cerebral blood flow rate, while iron deficiency increases ventricular diameters.
INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING
(2023)
Article
Cardiac & Cardiovascular Systems
Ridha I. S. Alnuwaysir, Niels Grote Beverborg, Martijn F. Hoes, George Markousis-Mavrogenis, Karla A. Gomez, Haye H. van der Wal, John G. F. Cleland, Kenneth Dickstein, Chim C. Lang, Leong L. Ng, Piotr Ponikowski, Stefan D. Anker, Dirk J. van Veldhuisen, Adriaan A. Voors, Peter van der Meer
Summary: Iron deficiency, chronic kidney disease, and/or anemia in patients with heart failure have significant overlap in biomarker profiles, indicating common pathways associated with these syndromes. Iron deficiency alone or on top of chronic kidney disease and anemia is associated with worse quality of life, exercise capacity, and prognosis in patients with worsening heart failure.
EUROPEAN JOURNAL OF HEART FAILURE
(2022)
Article
Cardiac & Cardiovascular Systems
Piotr Ponikowski, Robert J. Mentz, Adrian F. Hernandez, Javed Butler, Muhammad Shahzeb Khan, Dirk J. van Veldhuisen, Bernard Roubert, Nicole Blackman, Tim Friede, Ewa A. Jankowska, Stefan D. Anker
Summary: This meta-analysis of intravenous ferric carboxymaltose therapy for iron-deficient heart failure patients found a significantly reduced risk of hospitalizations for HF and cardiovascular causes, with no apparent effect on mortality.
EUROPEAN HEART JOURNAL
(2023)
Review
Medicine, General & Internal
Ridha I. S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, Peter van der Meer, Niels Grote Beverborg
Summary: Iron deficiency is a common comorbidity in heart failure patients and can have negative effects on exercise capacity, quality of life, hospitalization rates, and mortality risks. Intravenous iron correction has shown promising results in improving symptoms and reducing hospitalizations in heart failure patients. However, the underlying pathophysiology of iron deficiency in heart failure is still poorly understood.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Jeness Campodonico, Flavia Nicoli, Irene Motta, Margherita Migone De Amicis, Alice Bonomi, Maria Cappellini, Piergiuseppe Agostoni
Summary: In patients with heart failure, anemia is associated with poor prognosis. Patients with TSAT <20% have worse prognosis compared to those with TSAT >= 20%, and patients with ferritin between 100 and 300 ug/L and TSAT <20% likely have the poorest survival rate.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
(2021)
Article
Gastroenterology & Hepatology
Jonathon Snook, Neeraj Bhala, Ian L. P. Beales, David Cannings, Chris Kightley, Robert Ph Logan, D. Mark Pritchard, Reena Sidhu, Sue Surgenor, Wayne Thomas, Ajay M. Verma, Andrew F. Goddard
Summary: Iron deficiency anaemia is a major global cause of disease burden, diagnosed through blood testing and treated with iron replacement therapy. Causes include poor diet and gastrointestinal pathologies, with endoscopy and radiological scanning used for diagnosis and assessment in some cases.
Article
Cardiac & Cardiovascular Systems
Craig J. Beavers, Andrew P. Ambrosy, Javed Butler, Beth T. Davidson, Stormi E. Gale, Ileana L. Pina, Ioannis Mastoris, Nosheen Reza, Robert J. Mentz, Gregory D. Lewis
Summary: Iron deficiency affects approximately 50% of symptomatic heart failure patients and is associated with worse functional capacity, lower quality of life, and increased mortality. This document aims to provide a summary of the definition, epidemiology, pathophysiology of iron deficiency in heart failure, as well as pharmacological considerations for iron repletion strategies. It also highlights the growing body of clinical trial evidence on when, how, and in whom to consider iron repletion.
JOURNAL OF CARDIAC FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Sarah Fitzsimons, Tee Joo Yeo, Lieng H. Ling, David Sim, Kui Toh Gerard Leong, Poh Shuan Daniel Yeo, Hean Yee Ong, Fazlur Jaufeerally, Tze P. Ng, Katrina Poppe, Mayanna Lund, Gerry Devlin, Richard Troughton, Carolyn S. P. Lam, A. Mark Richards, Robert N. Doughty
Summary: Iron deficiency is equally prevalent in HFpEF and HFrEF but is negatively prognostic only in HFrEF. Persistence of iron deficiency is strongly associated with mortality, while resolution is not as significant. IDTsat is the superior definition of iron deficiency and should be considered in future trials investigating the efficacy of intravenous iron replacement in patients with HFrEF.
Article
Medicine, General & Internal
Gema Minana, Miguel Lorenzo, Antonio Ramirez de Arellano, Sandra Wachter, Rafael de la Espriella, Clara Sastre, Anna Mollar, Eduardo Nunez, Vicent Bodi, Juan Sanchis, Antoni Bayes-Genis, Julio Nunez
Summary: This study investigated the incidence of iron deficiency and the clinical impact of intravenous iron on heart failure rehospitalization risk in stable heart failure patients. The results showed that iron deficiency was common in heart failure patients and iron repletion reduced the risk of recurrent heart failure hospitalizations.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Sarah Fitzsimons, Tee Joo Yeo, Lieng H. Ling, David Sim, Kui Toh Gerard Leong, Poh Shuan Daniel Yeo, Hean Yee Ong, Fazlur Jaufeerally, Tze P. Ng, Katrina Poppe, Mayanna Lund, Gerry Devlin, Richard Troughton, Carolyn S. P. Lam, A. Mark Richards, Robert N. Doughty
Summary: Iron deficiency is equally prevalent in HFpEF and HFrEF, but negatively impacts prognosis only in HFrEF. Persistent iron deficiency is strongly associated with mortality while resolution does not have a significant effect. Transferrin saturation is the superior definition of iron deficiency and should inform future trials investigating the efficacy of intravenous iron replacement in patients with HFrEF.
Review
Cardiac & Cardiovascular Systems
Andrew Sindone, Wolfram Doehner, Josep Comin-Colet
Summary: Intravenous iron-carbohydrate complex supplementation has a positive effect on heart failure patients, reducing hospitalization rates and improving functional and exercise capacity.
Article
Medicine, Research & Experimental
Michal Kosowski, Katarzyna Swoboda, Jan Chmura, Dorota Kustrzycka-Kratochwil, John A. Todd, Ewa A. Jankowska, Krzysztof Reczuch, Piotr Ponikowski
Summary: This study aimed to evaluate the effects of running a marathon on inflammatory biomarkers and cardiovascular function. The results showed a sharp rise of inflammatory and cardiovascular stress biomarkers after the race, but no correlation was found between immune activation and cardiac biomarker release. Cardiovascular imaging also did not show any myocardial damage due to ischemia or inflammation.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
(2023)
Article
Economics
Phil McEwan, Piotr Ponikowski, Tinevimbo Shiri, Giuseppe M. C. Rosano, Andrew J. S. Coats, Fabio Dorigotti, Antonio Ramirez de Arellano, Ewa A. Jankowska
Summary: This study evaluates the financial implications of introducing ferric carboxymaltose (FCM) for treating acute heart failure patients in the UK, Switzerland, and Italy. The findings suggest that FCM could lead to cost savings in the healthcare systems of these countries.
JOURNAL OF MEDICAL ECONOMICS
(2023)
Article
Multidisciplinary Sciences
Lidia Alcoberro, Pedro Moliner, Joan Vime, Santiago Jimenez-Marrero, Alberto Garay, Sergi Yun, Alexandra Pons-Riverola, Raul Ramos-Polo, Mar Ras-Jimenez, Marta Tajes, Encarna Hidalgo, Esther Calero, Marta Ruiz, Nuria Jose-Bazan, Carles Ferre, Cristina Delso, Laia Alcober, Cristina Enjuanes, Josep Comin-Colet
Summary: A new nurse-led coordinated transitional program for heart failure patients reduces the composite endpoint of death and hospitalization both at 90 and 180 days after discharge. This decrease is mainly driven by a reduction in cardiovascular and heart failure hospitalizations. A more exhaustive discharge planning process further reduces all-cause mortality.
Article
Medicine, General & Internal
Sandra Valdivielso More, Miren Vicente Elcano, Anna Garcia Alonso, Sergi Pascual Sanchez, Isabel Galceran Herrera, Francesc Barbosa Puig, Laia C. Belarte-Tornero, Sonia Ruiz-Bustillo, Ronald O. Morales O. Murillo, Clara Barrios, Joan Vime-Jubany, Nuria Farre
Summary: Despite being common in patients with advanced CKD, HF has been understudied. This retrospective study of 217 advanced CKD patients without RRT found a 40% prevalence of HF. Previous HF is associated with a high-risk profile and a worse prognosis, requiring close follow-up.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Health Care Sciences & Services
Helena Cristobal, Cristina Enjuanes, Montserrat Batlle, Marta Tajes, Begona Campos, Josep Francesch, Pedro Moliner, Marta Farrero, Rut Andrea, Jose Tomas Ortiz-Perez, Albert Morales, Manel Sabate, Josep Comin-Colet, Pablo Garcia de Frutos
Summary: Heart failure (HF) is classified based on left ventricular ejection fraction (EF) into HF with reduced, mildly reduced, and preserved EF. Biomarkers may differ depending on EF type. This study analyzed the levels of soluble form of the AXL receptor tyrosine kinase (sAXL) in HF patients with reduced and preserved EF. The results showed that sAXL levels were a reliable predictor for all-cause and cardiovascular mortality only in the HFpEF cohort.
JOURNAL OF PERSONALIZED MEDICINE
(2023)
Article
Health Care Sciences & Services
Josep Comin Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchia, MariaIsabel del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sanchez
Summary: This observational and retrospective study analyzed healthcare resources usage and costs associated with nonvalvular atrial fibrillation (NVAF) in Spain. The results showed that compared to acenocoumarol, apixaban reduced the incidence of strokes and systemic embolisms, minor and major bleedings, and deaths. Apixaban also led to significant cost savings in nursing visits, hospitalizations, and emergency visits, with an annual saving of €274 per patient from the perspective of society. Therefore, apixaban is considered a cost-effective alternative for patients with NVAF.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
(2023)
Article
Public, Environmental & Occupational Health
Damia Valero-Bover, David Monterde, Gerard Carot-Sans, Miguel Cainzos-Achirica, Josep Comin-Colet, Emili Vela, Montse Cleries, Julia Folguera, Sonia Abilleira, Miquel Arrufat, Yolanda Lejardi, Oscar Solans, Toni Dedeu, Marc Coca, Pol Perez-Sust, Caridad Pontes, Jordi Piera-Jimenez
Summary: The study aimed to assess the contribution of age and comorbidity to the risk of critical illness in hospitalized COVID-19 patients using increasingly exhaustive tools for measuring comorbidity burden. It was found that comorbidity burden explained better than chronological age the increased risk of critical illness observed in patients hospitalized with COVID-19.
CLINICAL EPIDEMIOLOGY
(2023)
Article
Medicine, General & Internal
Agnieszka Matera-Witkiewicz, Magdalena Krupinska, Adrian Doroszko, Malgorzata Trocha, Katarzyna Giniewicz, Krzysztof Kujawa, Maciej Rabczynski, Marta Obremska, Edwin Kuznik, Pawel Lubieniecki, Barbara Adamik, Krzysztof Kaliszewski, Katarzyna Kilis-Pstrusinska, Michal Pomorski, Marcin Protasiewicz, Marcin Madziarski, Janusz Sokolowski, Ewa A. Jankowska, Katarzyna Madziarska
Summary: Advanced age is a predictor for COVID-19 severity. The VACO index, along with past medical records, can be used to predict short-term mortality and disease progression.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Biochemistry & Molecular Biology
Mateusz Sokolski, Marta Kaluzna-Oleksy, Agnieszka Tycinska, Ewa A. Jankowska
Summary: Studies have found that patients with heart failure (HF) and COVID-19 have a higher risk of complications and mortality. The pandemic has disrupted access to standard procedures, leading to increased mortality in HF patients and the need for reorganisation of healthcare systems. New technologies, such as telemedicine and remote monitoring, have shown promise in addressing the challenges faced by HF patients during the pandemic and are likely to be further developed in the future.
Article
Health Care Sciences & Services
Maria del Mar Ras-Jimenez, Raul Ramos-Polo, Josep Francesch Manzano, Miriam Corbella Santano, Herminio Morillas Climent, Nuria Jose-Bazan, Santiago Jimenez-Marrero, Paloma Garcimartin Cerezo, Sergi Yun Viladomat, Pedro Moliner Borja, Blanca Torres Cardus, Jose Maria Verdu-Rotellar, Carles Diez-Lopez, Jose Gonzalez-Costello, Elena Garcia-Romero, Fernando de Frutos Seminario, Laura Triguero-Llonch, Cristina Enjuanes Grau, Marta Tajes Orduna, Josep Comin-Colet
Summary: The soluble transferrin receptor (sTfR) is a marker of tissue iron status that indicates an increased iron demand. This study found that, in non-anemic heart failure patients with normal systemic iron status, higher levels of sTfR were associated with impaired functional capacity and worse quality of life.
JOURNAL OF PERSONALIZED MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Jacek Grzybowski, Piotr Podolec, Katarzyna Holcman, Monika Gawor-Prokopczyk, Ewa Jankowska, Magdalena Kostkiewicz, Alicja Dabrowska-Kugacka, Marta Lipowska, Lukasz Mazurkiewicz, Renata Rajtar-Salwa, Pawel Rubis, Ewa Straburzynska-Migaj, Justyna Szczygiel, Przemyslaw Mitkowski, Zbigniew Gasior, Przemyslaw Leszek
Summary: Considering the low prevalence of ATTR-CM in Poland, this article addresses the challenges faced by patients in terms of diagnosis and treatment. It presents recommended diagnostic algorithms involving laboratory workup, imaging tests, and genetic tests. Additionally, it discusses distinguishing ATTR-CM from light chain amyloidosis, neurological manifestations, therapeutic options, and nonpharmacological treatment recommendations. The need for accessing causative treatment with tafamidis is emphasized.
KARDIOLOGIA POLSKA
(2023)
Article
Medicine, General & Internal
Patryk Szlacheta, Jolanta Malinowska-Borowska, Jolanta U. Nowak, Marta Buczkowska, Aleksandra Kulik, Alina Mroczek, Sylwia Duda, Weronika Ostrega, Jacek T. Niedziela, Michal Skrzypek, Mariusz Gasior, Piotr Rozentryt
Summary: This study assessed the prognostic value of red cell distribution width (RDW) in chronic heart failure with reduced ejection fraction (HFrEF), and found that RDW has a strong independent prognostic power regardless of the risk assessed by MAGGIC-HF or SHFSM score.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ
(2023)